Alliancebernstein L.P. Increases Stock Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

Alliancebernstein L.P. lifted its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 357.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 130,000 shares of the company's stock after buying an additional 101,560 shares during the quarter. Alliancebernstein L.P. owned approximately 0.32% of Phibro Animal Health worth $2,730,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Rhumbline Advisers raised its holdings in shares of Phibro Animal Health by 0.6% in the 4th quarter. Rhumbline Advisers now owns 76,582 shares of the company's stock valued at $1,608,000 after purchasing an additional 484 shares in the last quarter. Los Angeles Capital Management LLC increased its holdings in Phibro Animal Health by 2.1% during the fourth quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company's stock valued at $505,000 after buying an additional 503 shares during the period. New York State Teachers Retirement System raised its stake in Phibro Animal Health by 16.7% in the fourth quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock worth $114,000 after buying an additional 775 shares in the last quarter. SG Americas Securities LLC lifted its holdings in Phibro Animal Health by 7.4% during the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock worth $276,000 after buying an additional 906 shares during the period. Finally, Globeflex Capital L P boosted its position in Phibro Animal Health by 0.8% during the 4th quarter. Globeflex Capital L P now owns 206,595 shares of the company's stock valued at $4,338,000 after acquiring an additional 1,700 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

PAHC has been the subject of several recent research reports. Morgan Stanley set a $20.00 price target on Phibro Animal Health in a research report on Tuesday, April 15th. Barclays increased their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research report on Monday, February 10th. Finally, StockNews.com downgraded shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a research report on Tuesday, March 25th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company's stock. According to MarketBeat, Phibro Animal Health currently has an average rating of "Hold" and an average price target of $19.75.

Phibro Animal Health Stock Up 2.7 %

Phibro Animal Health stock traded up $0.46 during midday trading on Friday, reaching $17.29. The company's stock had a trading volume of 241,189 shares, compared to its average volume of 191,577. Phibro Animal Health Co. has a 52-week low of $12.30 and a 52-week high of $26.55. The stock has a market capitalization of $700.30 million, a P/E ratio of 36.02, a PEG ratio of 0.45 and a beta of 0.63. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The stock's 50-day simple moving average is $21.46 and its 200-day simple moving average is $22.30.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, sell-side analysts expect that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.78%. The ex-dividend date was Wednesday, March 5th. Phibro Animal Health's dividend payout ratio (DPR) is presently 100.00%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.